WallStSmart

Harte Hanks Inc (HHS)vsHoneywell International Inc (HON)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Honeywell International Inc generates 24154% more annual revenue ($37.66B vs $155.27M). HON leads profitability with a 10.9% profit margin vs -0.7%. HHS appears more attractively valued with a PEG of 1.19. HON earns a higher WallStSmart Score of 53/100 (C-).

HHS

Hold

40

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 4.3Quality: 5.5
Piotroski: 3/9Altman Z: 14.61

HON

Buy

53

out of 100

Grade: C-

Growth: 3.3Profit: 7.0Value: 4.3Quality: 5.5
Piotroski: 4/9Altman Z: 2.05
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HHSSignificantly Overvalued (-54.3%)

Margin of Safety

-54.3%

Fair Value

$1.86

Current Price

$2.60

$0.74 premium

UndervaluedFair: $1.86Overvalued

Intrinsic value data unavailable for HON.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HHS2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
14.6110/10

Safe zone — low bankruptcy risk

HON2 strengths · Avg: 8.5/10
Market CapQuality
$141.47B9/10

Large-cap with strong market position

Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

Areas to Watch

HHS4 concerns · Avg: 2.8/10
Market CapQuality
$18.85M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.103/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-5.2%2/10

ROE of -5.2% — below average capital efficiency

HON4 concerns · Avg: 4.0/10
PEG RatioValuation
2.144/10

Expensive relative to growth rate

P/E RatioValuation
35.7x4/10

Premium valuation, high expectations priced in

Price/BookValuation
10.0x4/10

Trading at 10.0x book value

Revenue GrowthGrowth
2.4%4/10

2.4% revenue growth

Comparative Analysis Report

WallStSmart Research

Bull Case : HHS

The strongest argument for HHS centers on Price/Book, Altman Z-Score. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bull Case : HON

The strongest argument for HON centers on Market Cap, Operating Margin.

Bear Case : HHS

The primary concerns for HHS are Market Cap, Debt/Equity, Piotroski F-Score.

Bear Case : HON

The primary concerns for HON are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 1.58 is elevated, increasing financial risk.

Key Dynamics to Monitor

HHS profiles as a turnaround stock while HON is a value play — different risk/reward profiles.

HON carries more volatility with a beta of 0.81 — expect wider price swings.

HON is growing revenue faster at 2.4% — sustainability is the question.

HHS generates stronger free cash flow (-903,000), providing more financial flexibility.

Bottom Line

HON scores higher overall (53/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Harte Hanks Inc

INDUSTRIALS · CONGLOMERATES · USA

Harte Hanks, Inc. is a customer experience company in the United States and internationally. The company is headquartered in Chelmsford, Massachusetts.

Visit Website →

Honeywell International Inc

INDUSTRIALS · CONGLOMERATES · USA

Honeywell International Inc. is an American publicly traded, multinational conglomerate headquartered in Charlotte, North Carolina. It primarily operates in four areas of business: aerospace, building technologies, performance materials and technologies (PMT), and safety and productivity solutions (SPS).

Want to dig deeper into these stocks?